Payment overview · 2025
General Payments
$882.07
30 reported records · 6 companies
Healthcare provider profile · identity verified
Eduard Zinger, MD
Allopathic & Osteopathic Physicians|Internal Medicine · LINCOLNWOOD, IL · NPI 1346276656
Verified facts
What the public records show
CMS Open Payments records show Eduard Zinger, MD received $882.07 in general payments during 2025 across 30 reported records.
ABBVIE INC. accounted for 35.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 12 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Creon, Farxiga, Linzess, Ozempic.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported CREON as an associated drug or biological on 91561 records involving 20616 distinct recipient NPIs. Public Medicare Part D data also shows 423 claims for Creon by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 431 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LUMIGAN as an associated drug or biological on 25016 records involving 7645 distinct recipient NPIs. Public Medicare Part D data also shows 12 claims for Lumigan by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 115 claims for Synthroid by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BRILINTA as an associated drug or biological on 993 records involving 512 distinct recipient NPIs. Public Medicare Part D data also shows 16 claims for Brilinta by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 330 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NEXIUM as an associated drug or biological on 464 records involving 299 distinct recipient NPIs. Public Medicare Part D data also shows 17 claims for Nexium by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 20 claims for Symbicort by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 86 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ABBVIE INC. | Unresolved — no canonical attribution shown | $309.00 | 35.0% | 11 | 2025 |
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $232.84 | 26.4% | 9 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $144.81 | 16.4% | 2 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $95.92 | 10.9% | 4 | 2025 |
| Ardelyx, Inc. | Unresolved — no canonical attribution shown | $74.35 | 8.4% | 3 | 2025 |
| IDORSIA PHARMACEUTICALS US INC | Unresolved — no canonical attribution shown | $25.15 | 2.9% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $882.07 | 30 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| CREON Normalized: creon |
Drug | ABBVIE INC. | $254.88 | 9 | 2025 |
Source payment records
|
|||||
| VIBERZI Normalized: viberzi |
Drug | ABBVIE INC. | $254.88 | 9 | 2025 |
Source payment records
|
|||||
| FARXIGA Normalized: farxiga |
Drug | AstraZeneca Pharmaceuticals LP | $203.19 | 8 | 2025 |
Source payment records
|
|||||
| Wegovy Normalized: wegovy |
Drug | Novo Nordisk Inc | $123.95 | 1 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $95.92 | 4 | 2025 |
Source payment records
|
|||||
| IBSRELA Normalized: ibsrela |
Drug | Ardelyx, Inc. | $74.35 | 3 | 2025 |
Source payment records
|
|||||
| LINZESS Normalized: linzess |
Drug | ABBVIE INC. | $54.12 | 2 | 2025 |
Source payment records
|
|||||
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $46.77 | 2 | 2025 |
Source payment records
|
|||||
| AIRSUPRA Normalized: airsupra |
Drug | AstraZeneca Pharmaceuticals LP | $29.65 | 1 | 2025 |
Source payment records
|
|||||
| Quviviq Normalized: quviviq |
Drug | IDORSIA PHARMACEUTICALS US INC | $25.15 | 1 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $20.86 | 1 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $20.86 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| CREON creon |
2025 | Creon | 2024 | 423 | exact normalized | Medicare Part D |
| FARXIGA farxiga |
2025 | Farxiga | 2024 | 330 | exact normalized | Medicare Part D |
| LINZESS linzess |
2025 | Linzess | 2024 | 431 | exact normalized | Medicare Part D |
| Ozempic ozempic |
2025 | Ozempic | 2024 | 86 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | CREON open payments reported associated product |
CMS Open Payments — General Payments 91561 supporting records · 20616 recipient NPIs · example record 1201352608 |
Creon · 2024 Exact normalized brand match · 1 Part D row |
423 | 73 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
431 | 75 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LUMIGAN open payments reported associated product |
CMS Open Payments — General Payments 25016 supporting records · 7645 recipient NPIs · example record 1201352548 |
Lumigan · 2024 Exact normalized brand match · 1 Part D row |
12 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
115 | 16 |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | BRILINTA open payments reported associated product |
CMS Open Payments — General Payments 993 supporting records · 512 recipient NPIs · example record 1206131430 |
Brilinta · 2024 Exact normalized brand match · 1 Part D row |
16 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
330 | 59 |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | NEXIUM open payments reported associated product |
CMS Open Payments — General Payments 464 supporting records · 299 recipient NPIs · example record 1206134180 |
Nexium · 2024 Exact normalized brand match · 1 Part D row |
17 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
20 | suppressed by CMS |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
86 | 18 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1357 | 217 |
| Levothyroxine Sodium | Levothyroxine Sodium | 944 | 125 |
| Amlodipine Besylate | Amlodipine Besylate | 916 | 150 |
| Omeprazole | Omeprazole | 913 | 138 |
| Diclofenac Sodium | Diclofenac Sodium | 866 | 145 |
| Metoprolol Succinate | Metoprolol Succinate | 776 | 133 |
| Metformin Hcl | Metformin Hcl | 699 | 108 |
| Lidocaine | Lidocaine | 681 | 111 |
| Lisinopril | Lisinopril | 672 | 83 |
| Furosemide | Furosemide | 642 | 114 |
| Valsartan | Valsartan | 591 | 104 |
| Tramadol Hcl | Tramadol Hcl | 522 | 99 |
| Eliquis | Apixaban | 506 | 81 |
| Tamsulosin Hcl | Tamsulosin Hcl | 485 | 77 |
| Gabapentin | Gabapentin | 450 | 75 |
| Meclizine Hcl | Meclizine Hcl | 437 | 74 |
| Vascepa | Icosapent Ethyl | 436 | 57 |
| Linzess | Linaclotide | 431 | 75 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 428 | 77 |
| Creon | Lipase/Protease/Amylase | 423 | 73 |
| Zolpidem Tartrate | Zolpidem Tartrate | 413 | 80 |
| Losartan Potassium | Losartan Potassium | 394 | 62 |
| Nifedipine Er | Nifedipine | 394 | 62 |
| Hydralazine Hcl | Hydralazine Hcl | 390 | 57 |
| Pantoprazole Sodium | Pantoprazole Sodium | 367 | 57 |
| Clonazepam | Clonazepam | 346 | 55 |
| Farxiga | Dapagliflozin Propanediol | 330 | 59 |
| Potassium Chloride | Potassium Chloride | 327 | 57 |
| Carvedilol | Carvedilol | 316 | 51 |
| Donepezil Hcl | Donepezil Hcl | 315 | 39 |
| Sertraline Hcl | Sertraline Hcl | 314 | 48 |
| Fluticasone Propionate | Fluticasone Propionate | 301 | 72 |
| Quetiapine Fumarate | Quetiapine Fumarate | 299 | 43 |
| Metoprolol Tartrate | Metoprolol Tartrate | 290 | 54 |
| Hydrochlorothiazide | Hydrochlorothiazide | 274 | 45 |
| Allopurinol | Allopurinol | 273 | 38 |
| Simvastatin | Simvastatin | 271 | 46 |
| Escitalopram Oxalate | Escitalopram Oxalate | 260 | 37 |
| Lorazepam | Lorazepam | 255 | 45 |
| Clonidine Hcl | Clonidine Hcl | 246 | 42 |
| Dexlansoprazole Dr | Dexlansoprazole | 244 | 40 |
| Pregabalin | Pregabalin | 239 | 44 |
| Trazodone Hcl | Trazodone Hcl | 235 | 36 |
| Famotidine | Famotidine | 228 | 32 |
| Clopidogrel | Clopidogrel Bisulfate | 222 | 34 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 213 | 41 |
| Jardiance | Empagliflozin | 210 | 28 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 192 | 30 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 188 | 42 |
| Spironolactone | Spironolactone | 185 | 30 |
| Januvia | Sitagliptin Phosphate | 181 | 23 |
| Myrbetriq | Mirabegron | 175 | 36 |
| Celecoxib | Celecoxib | 171 | 28 |
| Xarelto | Rivaroxaban | 171 | 27 |
| Tacrolimus | Tacrolimus | 151 | 26 |
| Ketoconazole | Ketoconazole | 150 | 30 |
| Alprazolam | Alprazolam | 148 | 23 |
| Citalopram Hbr | Citalopram Hydrobromide | 148 | 20 |
| Glipizide Er | Glipizide | 146 | 22 |
| Azelastine Hcl | Azelastine Hcl | 144 | 31 |
| Ammonium Lactate | Ammonium Lactate | 143 | 30 |
| Nitroglycerin | Nitroglycerin | 143 | 33 |
| Clonidine | Clonidine | 139 | 25 |
| Nebivolol Hcl | Nebivolol Hcl | 139 | 24 |
| Atenolol | Atenolol | 134 | 20 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 133 | 23 |
| Metformin Hcl Er | Metformin Hcl | 129 | 18 |
| Meloxicam | Meloxicam | 128 | 26 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 121 | 23 |
| Mirtazapine | Mirtazapine | 120 | 24 |
| Dicyclomine Hcl | Dicyclomine Hcl | 119 | 21 |
| Alendronate Sodium | Alendronate Sodium | 116 | 20 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 116 | 15 |
| Labetalol Hcl | Labetalol Hcl | 115 | 18 |
| Synthroid | Levothyroxine Sodium | 115 | 16 |
| Levetiracetam | Levetiracetam | 113 | 12 |
| Bumetanide | Bumetanide | 110 | 16 |
| Ventolin Hfa | Albuterol Sulfate | 108 | 25 |
| Glimepiride | Glimepiride | 103 | 24 |
| Procto-Med Hc | Hydrocortisone | 103 | 24 |
| Ibuprofen | Ibuprofen | 102 | 36 |
| Duloxetine Hcl | Duloxetine Hcl | 100 | 17 |
| Enalapril Maleate | Enalapril Maleate | 99 | 20 |
| Montelukast Sodium | Montelukast Sodium | 96 | 15 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 93 | 16 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 90 | 13 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 88 | suppressed |
| Ozempic | Semaglutide | 86 | 18 |
| Baclofen | Baclofen | 85 | 16 |
| Glipizide | Glipizide | 85 | 14 |
| Irbesartan | Irbesartan | 85 | 14 |
| Finasteride | Finasteride | 83 | 13 |
| Zenpep | Lipase/Protease/Amylase | 82 | 17 |
| Pioglitazone Hcl | Pioglitazone Hcl | 79 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 79 | suppressed |
| Lansoprazole | Lansoprazole | 78 | 12 |
| Nystatin | Nystatin | 78 | 30 |
| Warfarin Sodium | Warfarin Sodium | 78 | suppressed |
| Dutasteride | Dutasteride | 77 | 14 |
| Nitroglycerin Patch | Nitroglycerin | 77 | suppressed |
| Temazepam | Temazepam | 76 | 12 |
| Primidone | Primidone | 75 | suppressed |
| Proctozone-Hc | Hydrocortisone | 71 | 15 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 70 | 21 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 70 | 22 |
| Hydrocortisone | Hydrocortisone | 70 | 26 |
| Memantine Hcl Er | Memantine Hcl | 69 | suppressed |
| Ezetimibe | Ezetimibe | 66 | 13 |
| Fluocinonide-E | Fluocinonide/Emollient Base | 66 | 16 |
| Entresto | Sacubitril/Valsartan | 65 | 11 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 63 | 25 |
| Memantine Hcl | Memantine Hcl | 62 | 16 |
| Breo Ellipta | Fluticasone/Vilanterol | 59 | 14 |
| Tradjenta | Linagliptin | 57 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 56 | 13 |
| Levofloxacin | Levofloxacin | 55 | 43 |
| Ondansetron Hcl | Ondansetron Hcl | 55 | 18 |
| Digoxin | Digoxin | 54 | 13 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 51 | 11 |
| Metoclopramide Hcl | Metoclopramide Hcl | 51 | 16 |
| Colchicine | Colchicine | 50 | 11 |
| Febuxostat | Febuxostat | 50 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 50 | 23 |
| Benazepril Hcl | Benazepril Hcl | 47 | suppressed |
| Latanoprost | Latanoprost | 47 | suppressed |
| Azithromycin | Azithromycin | 46 | 46 |
| Loperamide | Loperamide Hcl | 46 | 17 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 46 | suppressed |
| Nyamyc | Nystatin | 46 | 16 |
| Prednisone | Prednisone | 46 | suppressed |
| Trulance | Plecanatide | 46 | 11 |
| Cyclosporine | Cyclosporine | 44 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 44 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 43 | 41 |
| Mupirocin | Mupirocin | 42 | 17 |
| Alcohol Pads | Alcohol Antiseptic Pads | 41 | 11 |
| Propranolol Hcl | Propranolol Hcl | 41 | suppressed |
| Topiramate | Topiramate | 41 | suppressed |
| Cephalexin | Cephalexin | 40 | 25 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 40 | suppressed |
| Invokana | Canagliflozin | 40 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 39 | suppressed |
| Torsemide | Torsemide | 39 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 38 | suppressed |
| Telmisartan | Telmisartan | 38 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 37 | suppressed |
| Alcohol Swab | Alcohol Antiseptic Pads | 36 | suppressed |
| Aripiprazole | Aripiprazole | 36 | suppressed |
| Bupropion Xl | Bupropion Hcl | 36 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 36 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 36 | suppressed |
| Belsomra | Suvorexant | 33 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 33 | suppressed |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 33 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 33 | suppressed |
| Lovastatin | Lovastatin | 33 | suppressed |
| Pro Comfort Alcohol Pads | Alcohol Antiseptic Pads | 33 | 18 |
| Tizanidine Hcl | Tizanidine Hcl | 33 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 33 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 32 | 12 |
| Fenofibrate | Fenofibrate Nanocrystallized | 32 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 32 | suppressed |
| Sucralfate | Sucralfate | 32 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 31 | suppressed |
| Lubiprostone | Lubiprostone | 31 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 31 | suppressed |
| Trulicity | Dulaglutide | 31 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 29 | suppressed |
| Prenatal Vitamin Plus Low Iron | Pnv,calcium 72/Iron/Folic Acid | 29 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 28 | 12 |
| Amitriptyline Hcl | Amitriptyline Hcl | 28 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 28 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 28 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 28 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 28 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 28 | 14 |
| Glycopyrrolate | Glycopyrrolate | 27 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 27 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 26 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 26 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 25 | 14 |
| Pentoxifylline | Pentoxifylline | 25 | suppressed |
| Ranolazine Er | Ranolazine | 25 | suppressed |
| Halobetasol Propionate | Halobetasol Propionate | 24 | suppressed |
| Alcohol Swabs | Alcohol Antiseptic Pads | 23 | 11 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 23 | suppressed |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 23 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 23 | suppressed |
| Fenofibrate | Fenofibrate | 23 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 23 | suppressed |
| Restasis | Cyclosporine | 23 | suppressed |
| Methimazole | Methimazole | 22 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 21 | 20 |
| Benztropine Mesylate | Benztropine Mesylate | 20 | suppressed |
| Ondansetron Odt | Ondansetron | 20 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 20 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 20 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 20 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 19 | 14 |
| Fluocinonide | Fluocinonide | 19 | 13 |
| Gemtesa | Vibegron | 19 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 19 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 19 | suppressed |
| Mounjaro | Tirzepatide | 19 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 19 | suppressed |
| Acarbose | Acarbose | 18 | suppressed |
| Betamethasone Valerate | Betamethasone Valerate | 18 | suppressed |
| Estradiol | Estradiol | 17 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 17 | suppressed |
| Nexium | Esomeprazole Magnesium | 17 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 17 | 17 |
| Timolol Maleate | Timolol Maleate | 17 | suppressed |
| Brilinta | Ticagrelor | 16 | suppressed |
| Calcitriol | Calcitriol | 16 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 16 | suppressed |
| Lactulose | Lactulose | 16 | suppressed |
| Methotrexate | Methotrexate Sodium | 16 | suppressed |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 16 | 14 |
| Olanzapine | Olanzapine | 16 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 16 | suppressed |
| Travoprost | Travoprost | 16 | suppressed |
| Cilostazol | Cilostazol | 15 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 15 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 15 | suppressed |
| Novolog Flexpen | Insulin Aspart | 15 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 15 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 14 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 14 | suppressed |
| Clotrimazole | Clotrimazole | 14 | suppressed |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 14 | suppressed |
| Felodipine Er | Felodipine | 14 | suppressed |
| Methylprednisolone | Methylprednisolone | 14 | 12 |
| Neomycin-Polymyxin-Hydrocort | Neomycin/Polymyxin B/Hydrocort | 14 | 12 |
| Santyl | Collagenase Clostridium Hist. | 14 | suppressed |
| Sotalol | Sotalol Hcl | 14 | suppressed |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 14 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 13 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 13 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 13 | suppressed |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 13 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 13 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 13 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 13 | suppressed |
| Lyrica | Pregabalin | 13 | suppressed |
| Naratriptan Hcl | Naratriptan Hcl | 13 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 13 | suppressed |
| Pindolol | Pindolol | 13 | suppressed |
| Selenium Sulfide | Selenium Sulfide | 13 | suppressed |
| Single Use Swab | Alcohol Antiseptic Pads | 13 | 11 |
| Toprol Xl | Metoprolol Succinate | 13 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 12 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 12 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 12 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 12 | suppressed |
| Lumigan | Bimatoprost | 12 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 12 | suppressed |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 12 | suppressed |
| Trimethoprim | Trimethoprim | 12 | suppressed |
| Alogliptin | Alogliptin Benzoate | 11 | suppressed |
| Amoxicillin | Amoxicillin | 11 | suppressed |
| Anastrozole | Anastrozole | 11 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 11 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 11 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 11 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 11 | suppressed |
| Ertapenem | Ertapenem Sodium | 11 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 11 | suppressed |
| Ibu | Ibuprofen | 11 | suppressed |
| Levemir | Insulin Detemir | 11 | suppressed |
| Metformin Er Gastric | Metformin Hcl | 11 | suppressed |
| Scopolamine | Scopolamine | 11 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 11 | suppressed |
| Ssd | Silver Sulfadiazine | 11 | suppressed |
| Xiidra | Lifitegrast | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $882.07 · 30 records | ABBVIE INC. | AIRSUPRA, CREON, FARXIGA, IBSRELA, LINZESS, OTEZLA, Ozempic, Quviviq, REPATHA, Rybelsus, VIBERZI, Wegovy | 9 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Creon play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error